Pro Share Advisors LLC Stoke Therapeutics, Inc. Transaction History
Pro Share Advisors LLC
- $48.7 Billion
- Q2 2025
A detailed history of Pro Share Advisors LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 10,444 shares of STOK stock, worth $364,913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,444
Previous 10,164
2.75%
Holding current value
$364,913
Previous $67,000
76.12%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding STOK
# of Institutions
138Shares Held
58MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$189 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$189 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$179 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$162 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$153 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.38B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...